We are live on ! Find out more
JIP

Jaffetilchin Investment Partners Portfolio holdings

AUM $1.68B
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+22.81%
3 Year Est. Return
+78.52%
5 Year Est. Return
+93%
10 Year Est. Return
+323.14%
AUM
$705M
AUM Growth
+$163M
Cap. Flow
+$99.7M
Cap. Flow %
14.14%
Top 10 Hldgs %
47.57%
Holding
300
New
77
Increased
112
Reduced
80
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 10.36%
2 Healthcare 4.58%
3 Consumer Discretionary 4.27%
4 Communication Services 3.19%
5 Financials 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWX icon
251
iShares MSCI ACWI ex US ETF
ACWX
$12B
$226K 0.03%
+4,257
New +$211K
TVTY
252
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$225K 0.03%
11,463
-9,347
-45% -$155K
PTON icon
253
Peloton Interactive
PTON
$2.38B
$223K 0.03%
+1,468
New +$179K
VTRS icon
254
Viatris
VTRS
$18.5B
$223K 0.03%
+11,885
New +$194K
XOM icon
255
ExxonMobil
XOM
$657B
$215K 0.03%
+5,211
New +$195K
BTG icon
256
B2Gold
BTG
$6.88B
$212K 0.03%
+37,875
New +$231K
FPX icon
257
First Trust US Equity Opportunities ETF
FPX
$1.53B
$212K 0.03%
+1,792
New +$194K
CB icon
258
Chubb
CB
$132B
$211K 0.03%
+1,369
New +$192K
CHS
259
DELISTED
Chicos FAS, Inc.
CHS
$210K 0.03%
131,776
-7,953
-6% -$11K
IYF icon
260
iShares US Financials ETF
IYF
$4.41B
$208K 0.03%
+3,108
New +$192K
CRSR icon
261
Corsair Gaming
CRSR
$1.4B
$207K 0.03%
+5,723
New +$174K
TEVA icon
262
Teva Pharmaceuticals
TEVA
$42.8B
$202K 0.03%
+20,965
New +$201K
VVR icon
263
Invesco Senior Income Trust
VVR
$457M
$172K 0.02%
43,171
+3,945
+10% +$14.9K
THCX
264
DELISTED
AXS Cannabis ETF
THCX
$148K 0.02%
1,184
GLV
265
Clough Global Dividend & Income Fund
GLV
$78.8M
$106K 0.02%
10,225
+99
+1% +$959
LITS
266
Lite Strategy Inc
LITS
$31.4M
$87K 0.01%
+1,650
New +$95.2K
PRTK
267
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$79K 0.01%
+12,675
New +$74.6K
ECOR icon
268
electroCore
ECOR
$84.7M
$69K 0.01%
2,970
-1,321
-31% -$32.5K
ET icon
269
Energy Transfer Partners
ET
$72.1B
$62K 0.01%
+10,100
New +$61.1K
BRW
270
Saba Capital Income & Opportunities Fund
BRW
$335M
$56K 0.01%
+6,264
New +$55.2K
MDIA icon
271
Mediaco Holding
MDIA
$78.3M
$41K 0.01%
+15,889
New +$43.4K
ADMA icon
272
ADMA Biologics
ADMA
$2.19B
$28K ﹤0.01%
+14,250
New +$30K
ETTX
273
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$27K ﹤0.01%
+11,000
New +$21.6K
ZOM
274
DELISTED
Zomedica Corp.
ZOM
$5K ﹤0.01%
+20,500
New +$2.61K
AYTU icon
275
AYTU BioPharma
AYTU
$25.3M
-72
Closed -$17K

Similar funds

Jaffetilchin Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Jaffetilchin Investment Partners held 300 positions worth $705M, up 30% from $542M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Jaffetilchin Investment Partners deployed $99.7M of net new capital in Q4 2020, opening 77 new positions and adding to 112 existing holdings. Its largest new stake was KraneShares CSI China Internet ETF: 52,478 shares worth $4.03M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $6.18M trimmed.

  • Jaffetilchin Investment Partners's largest Q4 2020 buy was KraneShares CSI China Internet ETF: 52,478 shares worth $4.03M.
  • Jaffetilchin Investment Partners added most to First Trust Enhanced Short Maturity ETF in Q4 2020, an estimated $14.3M increase.
  • Jaffetilchin Investment Partners's biggest Q4 2020 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $6.18M.
  • Jaffetilchin Investment Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2020, selling an estimated $6.05M.
  • Jaffetilchin Investment Partners's ten largest holdings make up 48% of its $705M portfolio in Q4 2020.
  • Jaffetilchin Investment Partners opened 77 new positions and closed 26 in Q4 2020.
  • Jaffetilchin Investment Partners's portfolio value rose 30% quarter-over-quarter to $705M.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.